AI4CMR and Ligence announce a Strategic Partnership

Kaunas, Lithuania and Braga, Portugal – July 1, 2025

AI4CMR and Ligence are pleased to announce a strategic partnership aimed at transforming the efficiency and scalability of cardiology diagnostics through artificial intelligence.

This collaboration brings together two pioneering medical imaging companies with a shared vision: to streamline cardiac imaging workflows, enhance diagnostic precision, and reduce reporting times across clinical environments. Together, they aim to deliver greater value to both patients and healthcare providers.

“In many institutions, clinicians face increasing pressure to handle growing imaging volumes with limited resources,” said Antonio Murta, CEO of AI4CMR. “This partnership supports our mission to democratize access to cardiac imaging and improve patient outcomes through scalable, high-quality automation.”

By combining the advanced AI solutions of AI4CMR in cardiac MRI and Ligence in echocardiography, this partnership delivers a combined multimodality solution that helps hospitals and imaging centers streamline diagnostic workflows, reduce reporting time, and ensure consistent, high-quality care across cardiac imaging.

“This alliance with AI4CMR represents another milestone in our commitment to digital innovation in Cardiology,” said Arnas Karužas, CEO of Ligence. “Together, we are bridging diagnostic silos and creating smarter, faster workflows that benefit clinicians and patients alike.”

The joint offering supports CE-MDR and FDA-certified technology, ensuring compliance with regulatory standards while enabling advanced analytics to be embedded into routine clinical workflows. The partnership will focus initially on European deployment, with plans for broader global expansion.

About AI4CMR

AI4CMR is a cloud-native platform that fully automates cardiac MRI analysis, enabling consistent, high-quality reporting at scale. CE-MDR and FDA certified, AI4CMR integrates seamlessly with existing PACS, RIS, and cardiology IT ecosystems, helping radiology and cardiology teams reduce workload and improve reporting consistency.

About Ligence

Ligence develops AI-powered echocardiography automation tools that streamline cardiac ultrasound analysis and reporting. By reducing manual effort and improving reproducibility, Ligence enables clinicians to focus on delivering high-quality care. The company is headquartered in Vilnius, Lithuania, and serves healthcare institutions across
Europe.